Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$303,348
-$580,473 QoQ
Shares Held
1,404
-72.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#675
of 1,036 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Polymer Capital Management (US) LLC holds $2,503,906 across 7 Drug Manufacturers - General names. BIIB ranks #5 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
3,646 | $468,511 | |
| 2 | JNJ |
Johnson & Johnson
|
1,803 | $457,907 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
6,585 | $379,427 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,655 | $335,432 | |
| 5 | BIIB |
Biogen Inc.
This page
|
1,404 | $303,348 | |
| 6 | LLY |
ELI LILLY & Co
|
246 | $295,059 | |
| 7 | ABBV |
AbbVie Inc.
|
1,050 | $264,222 |
All Filings in BIIB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $303,348 | 1,404 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $883,821 | 5,022 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $374,573 | 2,674 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $472,218 | 3,760 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $530,939 | 3,880 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||